Abstract:Highlights • Our findings revealed a significant increase in sympathetic activity, for example, NE levels, in various mouse models of osteoarthritis, including natural aging, medial meniscus instability, and load-induced models. • Notably, alterations in the expression levels of β1-adrenergic receptor and SIRT6 were observed in chondrocytes of naturally aging osteoarthritis mouse models. • Our study highlights the role of sympathetic innervation in driving the transfer of exosomal miR-125 from osteoarthritic chondrocytes. • Our study found that sympathetic innervation leading to the disruption of subchondral bone homeostasis and exacerbation of cartilage damage in aging mice. • These findings shed light on the potential contribution of sympathetic regulation to the pathogenesis of aging-related osteoarthritis. Introduction Osteoarthritis (OA) is a progressive disease that poses a significant threat to human health, particularly in aging individuals: Although sympathetic activation has been implicated in bone metabolism, its role in the development of OA related to aging remains poorly understood. Therefore, this study aimed to investigate how sympathetic regulation impacts aging-related OA through experiments conducted both i n vivo and in vitro. Methods To analyze the effect of sympathetic regulation on aging-related OA, we conducted experiments using various mouse models. These models included a natural aging model, a medial meniscus instability model, and a load-induced model, which were used to examine the involvement of sympathetic nerves. In order to evaluate the expression levels of β1-adrenergic receptor ( Adrβ1 ) and sirtuin-6 ( Sirt6 ) in chondrocytes of naturally aging OA mouse models, we performed assessments. Additionally, we investigated the influence of β1-adrenergic receptor knockout or treatment with a β1-adrenergic receptor blocker on the progression of OA in aging mice and detected exosome release and detected downstream signaling expression by inhibiting exosome release. Furthermore, we explored the impact of sympathetic depletion through tyrosine hydroxylase ( TH ) on OA progression in aging mice. Moreover, we studied the effects of norepinephrine(NE)-induced activation of the β1-adrenergic receptor signaling pathway on the release of exosomes and miR-125 from chondrocytes, subsequently affecting osteoblast differentiation in subchondral bone. Results Our findings demonstrated a significant increase in sympathetic activity, such as NE levels, in various mouse models of OA including natural aging, medial meniscus instability, and load-induced models. Notably, we observed alterations in the expression levels of β1-adrenergic receptor and Sirt6 in chondrocytes in OA mouse models associated with natural aging, leading to an improvement in the progression of OA. Critically, we found that the knockout of β1-adrenergic receptor or treatment with a β1-adrenergic receptor blocker attenuated OA progression in aging mice and the degraded cartilage explants produced more exosome than the nondegraded ones, Moreover, sympathetic depletion through TH was shown to ameliorate OA progression in aging mice. Additionally, we discovered that NE-induced activation of the β1-adrenergic receptor signaling pathway facilitated the release of exosomes and miR-125 from chondrocytes, promoting osteoblast differentiation in subchondral bone. Conclusion In conclusion, our study highlights the role of sympathetic innervation in facilitating the transfer of exosomal miR-125 from osteoarthritic chondrocytes, ultimately disrupting subchondral bone homeostasis and exacerbating cartilage damage in aging mice. These findings provide valuable insights into the potential contribution of sympathetic regulation to the pathogenesis of aging-related OA. Graphical abstract Download : Download high-res image (301KB) <span class="anchor- -Abstract Truncated-

Stress-activated miR-204 governs senescent phenotypes of chondrocytes to promote osteoarthritis development

Reciprocal Inhibition of YAP/TAZ and NF-κB Regulates Osteoarthritic Cartilage Degradation

Wnt/β‑catenin Signaling May Induce Senescence of Chondrocytes in Osteoarthritis

miR-708-5p deficiency involves the degeneration of mandibular condylar chondrocytes via the TLR4/NF-κB pathway

miR-140 Attenuates the Progression of Early-Stage Osteoarthritis by Retarding Chondrocyte Senescence

MicroRNA-15a/β1,4-GalT-I Axis Contributes to Cartilage Degeneration Via NF-κB Signaling in Osteoarthritis

Targeting the senescence-related genes MAPK12 and FOS to alleviate osteoarthritis

MiR-653-5p drives osteoarthritis pathogenesis by modulating chondrocyte senescence

The Interplay Between Endoplasmic Reticulum Stress and Oxidative Stress in Chondrocyte Catabolism

Regulation of senescence associated signaling mechanisms in chondrocytes for cartilage tissue regeneration

CircRREB1 mediates lipid metabolism related senescent phenotypes in chondrocytes through FASN post-translational modifications

Inhibition of protein kinase CK2 facilitates cellular senescence by inhibiting the expression of HO-1 in articular chondrocytes

Small non-coding RNAome changes during human chondrocyte senescence as potential epigenetic targets in age-related osteoarthritis

Macrophage-derived ectosomal miR-350-3p promotes osteoarthritis progression through downregulating chondrocyte H3K36 methyltransferase NSD1

Changes in Small Noncoding RNA Expression during Chondrocyte Senescence

Loss of miR-204 and miR-211 shifts osteochondral balance and causes temporomandibular joint osteoarthritis

Sympathetic innervation induces exosomal miR-125 transfer from osteoarthritic chondrocytes, disrupting subchondral bone homeostasis and aggravating cartilage damage in aging mice

Senescent skeletal cells cross-talk with synovial cells plays a key role in the pathogenesis of osteoarthritis

Novel role of circRSU1 in the progression of osteoarthritis by adjusting oxidative stress

Mechanical stress abnormalities promote chondrocyte senescence - The pathogenesis of knee osteoarthritis

Role of GDF15/MAPK14 Axis in Chondrocyte Senescence as a Novel Senomorphic Agent in Osteoarthritis